BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pałasz A, Bogus K, Suszka-Świtek A, Kaśkosz A, Saint-Remy S, Piwowarczyk-Nowak A, Filipczyk Ł, Worthington JJ, Mordecka-Chamera K, Kostro K, Bajor G, Wiaderkiewicz R. The first identification of nesfatin-1-expressing neurons in the human bed nucleus of the stria terminalis. J Neural Transm (Vienna) 2019;126:349-55. [PMID: 30770997 DOI: 10.1007/s00702-019-01984-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Luo JJ, Wen FJ, Qiu D, Wang SZ. Nesfatin-1 in lipid metabolism and lipid-related diseases. Clin Chim Acta 2021;522:23-30. [PMID: 34389280 DOI: 10.1016/j.cca.2021.08.005] [Reference Citation Analysis]
2 Friedrich T, Stengel A. Role of the Novel Peptide Phoenixin in Stress Response and Possible Interactions with Nesfatin-1. Int J Mol Sci 2021;22:9156. [PMID: 34502065 DOI: 10.3390/ijms22179156] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Schalla MA, Unniappan S, Lambrecht NWG, Mori M, Taché Y, Stengel A. NUCB2/nesfatin-1 - Inhibitory effects on food intake, body weight and metabolism. Peptides 2020;128:170308. [PMID: 32229144 DOI: 10.1016/j.peptides.2020.170308] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
4 Pałasz A, Della Vecchia A, Saganiak K, Worthington JJ. Neuropeptides of the human magnocellular hypothalamus. J Chem Neuroanat 2021;117:102003. [PMID: 34280488 DOI: 10.1016/j.jchemneu.2021.102003] [Reference Citation Analysis]
5 Weibert E, Hofmann T, Elbelt U, Rose M, Stengel A. NUCB2/nesfatin-1 is associated with severity of eating disorder symptoms in female patients with obesity. Psychoneuroendocrinology 2022;143:105842. [PMID: 35752057 DOI: 10.1016/j.psyneuen.2022.105842] [Reference Citation Analysis]